NCODA Logo

Antiemesis Prophylaxis Remains Inadequate

Approximately 40% of patients treated with anthracyclines are still not receiving National Comprehensive Cancer Network (NCCN) guideline–adherent prophylaxis for chemotherapy-induced vomiting. In most cases, guideline nonadherence was secondary to the lack of a...

Medicines in Development for Cancer

A REPORT ON CANCERMore Than 800 Medicines and Vaccines in Clinical Testing for Cancer Offer New Hope to PatientsIn recent decades, tremendous – almost previously unthinkable – progress has been made in the fight against cancer. Advances in molecular and genomic...